The sale I've been running for two years just changed. If yours hasn't, read this.
Anthropic is reportedly closing a $30 billion round at a valuation north of $900 billion — which, if it closes at the high end, would make it more valuable than OpenAI for the first time. The same week, PwC announced it's certifying 30,000 US professionals on Claude and embedding Anthropic engineers inside the firm to build an entirely new finance business group from scratch. Insurance underwriting that took ten weeks now takes ten days. Security tasks that took hours take minutes. The Big Four have made their bets.
The enterprise AI sale — the one where you were creating category urgency, helping buyers understand why they couldn't afford to wait — is over. Your buyers made up their minds. The question now is whether you've updated your pitch.
I started my career at Crispin Porter + Bogusky when digital was the emerging channel nobody had a budget line for. Then I was at Oracle when mobile changed how enterprise buyers researched vendors. Then at Zeta when AI-powered acquisition was new enough that I had to explain what a model was before I could get to the demo. The pattern is always the same: there's a window where early category framing is the job, and then the window closes and the job becomes something else. Most sellers miss the transition.
The window on “AI is coming, you should get ready” closed sometime in the last six months. Here's what replaced it.
The old conversation
The AI sales motion from 2023 through early 2025 was fundamentally a change-management sale. You were selling urgency. The objection was philosophical: our organization isn't ready, our data isn't clean, we don't have the talent to manage it, our legal team has concerns. The job was to dismantle those objections one by one while building a coalition of internal champions who understood that the cost of inaction was compounding.
That was a real job, and I'm proud of what I built doing it. But if you're still running that motion in May 2026, you're selling to a customer who already bought — or you're selling to the 3% who have genuinely decided to sit it out.
The new conversation
Here's what I'm actually hearing now. “We deployed a pilot, it worked, but we're not sure we picked the right platform.” Or: “We're locked into a contract but we don't think we're getting the outcomes the vendor promised.” Or: “Our biggest competitor just announced a major partnership, and our board wants to know if we're behind.”
This is a different sale. The category anxiety is gone. Platform anxiety replaced it. Your buyers aren't asking whether AI is real. They're asking whether they picked the right bet, whether the deal they signed two years ago aged well, and whether switching costs are lower than staying costs. That is a much more specific conversation, and it requires a completely different set of proof points.
The PwC deal is instructive. PwC didn't announce a pilot. They announced a joint Center of Excellence, 30,000 professional certifications, and an entirely new finance business group built on top of Claude. That is not a buyer who is uncertain about the category. That is a buyer who has placed a long-duration bet and is building switching costs into their own workforce. The question their competitors are asking isn't “should we use AI?” It's “are we as committed as PwC is, and if not, what does that cost us?”
What changes in the room
Three things I've noticed shift in the conversations I'm having now.
First, the discovery question changed.In 2024, the most useful opener was “what's the cost of your team not having this?” In 2026, it's “what happened with the last AI deployment you ran?” The answer tells you everything: whether they're in the platform-anxiety conversation, whether they're nursing a failed pilot, or whether they're genuinely looking to expand what's already working.
Second, the proof that moves buyers changed.Case studies are less compelling than vendor stability signals. Buyers want to know: is this company going to exist in three years? Is the model I'm betting on going to compound, or get left behind? A $900B valuation and a $30B round from blue-chip institutional investors sends a very specific message to enterprise procurement committees. It's not about the technology anymore — it's about whether this is a platform worth betting your career on.
Third, the internal champion's job changed.In 2024, the champion was convincing the committee that AI was real. In 2026, they're defending a platform choice they already made or advocating for one that's better than what's already deployed. That's not persuasion — it's politics. Help them build the political case, not the category case.
The takeaway
If you're selling AI products right now, the next call you take should start with a diagnostic question: does your buyer need to be convinced the category is real, or do they need to be convinced your platform is the right one?
Most enterprise buyers I talk to are firmly in the second conversation. They're past the “should we do AI” phase and into the “which AI bet compounds for us” phase. The moment you realize which conversation you're in, everything changes — the framing, the proof points, the champion strategy, the close.
The category sale is over. The platform sale is just beginning. The sellers who figure that out this quarter will have a very different year than the ones still building decks around “the AI imperative.”